Umeclidinium + Vilanterol

Category: Lungs (Pulmonary)

Umeclidinium + Vilanterol Overview

Vilanterol (INN, USAN) is an ultra-long-acting β2 adrenoreceptor agonist (ultra-LABA), which was approved in May 2013 in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease (COPD).[1] Vilanterol is available in following combinations: with inhaled corticosteroid fluticasone furoate—fluticasone furoate/vilanterol (trade names Breo Ellipta (U.S.), Relvar Ellipta (EU, RU, JPN)) wit...

Read more Umeclidinium + Vilanterol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Umeclidinium + Vilanterol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Umeclidinium + Vilanterol
  • Powder: 0.0625mg/inh + 0.025mg/inh, 62.5mcg + 25mcg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (7 results)

Related Umeclidinium + Vilanterol Topics:

vilanterol. Is anoro available in east africa.
is anoiro ellipta available in Africa. I want to know if anoro ellipta is being marketed in africa...

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 1 March 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA